CFO moves week of June 15, 2026: 20 changes, pharma and software lead

The week of June 15, 2026 produced 20 CFO moves at US public companies, bringing the June month-to-date total to 62. Of the 20 events, 12 were transitions, 4 were interim appointments, 3 were appointments to seats with no outgoing CFO named, and 1 was a departure. Interim moves accounted for 20% of the week's activity.

Among the 19 seats counted as filled, 8 were external hires, 6 were internal promotions, and the origin of the remaining 5 could not be established. The table records 0 confirmed first-time CFOs; for 15 moves the question could not be established, and 4 were confirmed as not first-time appointments.

Pharmaceutical Preparations and Services-Prepackaged Software each recorded 3 moves, the most of any sector. Notable transitions in pharma included Petros Pharmaceuticals, Inc., where Robert Weinstein succeeded Mitchell Arnold effective June 18, and MapLight Therapeutics, Inc., where Jonathan Gillis stepped in as interim in place of Vishwas Setia on June 18.

The week's longest lead time before an effective date belongs to AT&T Inc.: Jennifer Biry is set to succeed Pascal Desroches on 2027-01-01, more than 6 months from the filing date. Philip Morris International Inc. announced Massimo Andolina will succeed Emmanuel Babeau effective 2026-08-01, while Newmont Corporation named Brian Tabolt to replace Peter Wexler effective 2026-07-01.

The week's sole departure was at Perfect Moment Ltd., where Chath Weerasinghe left and no incoming CFO was named; the effective date was not stated in the filing. The table records 0 departures with known tenure, so no median tenure figure is available this week.

Other moves included Mondelēz International, Inc. appointing Amit Banati effective 2026-07-01 with no outgoing CFO named, and F&G Annuities & Life, Inc. placing Mark Wiltse in an interim role succeeding Conor Murphy effective 2026-06-30.